References
- U.S. Department of Health and Human Services. Healthy People 2010. U.S. Government Printing Office, Washington, D.C. November 2000, 2nd edn
- Myers G. L., Miller W. G., Coresh J., Fleming J., Greenberg N., Greene T., et al. for the National Kidney Disease Education Program Laboratory Working Group: Recommendations for improving serum creatinine measurement – a report from the laboratory working group of the National Kidney Disease Education Program. Clin Chem 2006; 52: 5–18
- de Jong P. E., Curhan G. C. Screening, monitoring, and treatment of albuminuria: public health perspectives. J Am Soc Nephrol 2006; 17: 2120–6
- Boulware L. E., Troll M. U., Jaar B. G., Myers D. I., Powe N. R. Identification and referral of patients with progressive CKD: A national study. Am J Kidney Dis 2006; 48: 192–204
- National Center for Quality Assessment. The State of Health Care Quality 2005: Industry Trends and Analysis.. 38–39, Available at: http://www.ncqa.org/docs/sohcq_2005.pdf
- Saydah S., Eberhardt M., Rios‐Burrows N., Williams D., Geiss L., Dorsey R. Prevalence of chronic kidney disease and associated risk factors – United States, 1999–2004. MMWR Weekly 2007; 56: 161–5
- K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1